Navigation Links
Highly Regarded Medical Writer Joins Avant Healthcare Marketing Team

CARMEL, Ind., May 24 /PRNewswire/ -- Dynamic, thorough, and robustly qualified are a few of the many adjectives applied to our newest Scientific Content Consultant, Philippe Vitat, who brings with him expertise and an abundance of experience in the field. Mr. Vitat has worked as a certified medical writer and editor since 2001 and was named a "Leading Health Professional of the World" in medical education by the International Biographical Center in Cambridge, England. As a medical writer, he provided strategic consulting services in medical communications for major manufacturers, including Eli Lilly and Company, Ethicon, GlaxoSmithKline, AstraZeneca, Prometheus, Novartis, Eisai, and Sanofi-Aventis.

Mr. Vitat's therapeutic specialties include neuroscience, oncology, dermatology, gastroenterology, infectious diseases, and cardiovascular diseases, among others. He co-founded and served as medical editor of IMPACT, a Digestive Diseases Educational Center-produced regional CME symposium series, which continues to provide periodical clinical updates on digestive diseases, metabolic disorders, and infectious diseases throughout the United States.

Before working as a freelance medical writer, Mr. Vitat was Vice President and Group Account Supervisor at Grey Healthcare Group, a New York-based global healthcare communications company. While at Grey, he led numerous account teams that provided clients with project management support and elaborated a multi-faceted medical communications plan, which led, among other achievements, to the successful launch of Aciphex and Celexa. He also managed all operational aspects of the strategic partnership with Lilly leading to the global launch of the innovative biological agent Xigris.

Mr. Vitat received his baccalaureate in Economics at the College Sainte Marie in Antony, France, in 1987. He received his masters in Management with honors at the Ecole des Dirigeants et Createurs d'entreprise in Paris, France, in 1990 and his certificate in medical writing and editing at the University of Chicago Graham School of General Studies in 2008.

Avant Healthcare Marketing is recognized as a leader in peer-to-peer marketing for pharmaceutical and biotechnology companies who need comprehensive communication strategies and plans. Avant delivers superior medical and health education across multiple channels to healthcare professionals to improve patient outcomes.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Philippe Vitat

SOURCE Avant Healthcare Marketing
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Vi typhoid vaccine proves highly effective in young children
2. Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Antibodies(RM)
3. Thomson Reuters Examines Highly Cited Research in Bioterrorism
4. Scientists determine the structure of highly efficient light-harvesting molecules in green bacteria
5. NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains
6. HOGGAN Ergo Announces Highly Anticipated Enhancements to the ergoFET Handheld Digital Force Gauge, Greatly Impacting the Field of Ergonomic Research and Application
7. U.S. Risks Losing Highly Skilled Immigrants
8. NicOx Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen
9. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
10. Pharmatek Announces Official Opening of New Highly-Potent & Cytotoxic Development and Manufacturing Facility
11. Scientists demonstrate highly directional semiconductor lasers
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
Breaking Biology News(10 mins):